Key facts
- This page summarizes Joseph Romanelli's Form 4 filing for Merck & Co., Inc. (MRK).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 May 2025, 16:14.
Joseph Romanelli - 30 Apr 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)
- Reporting relationship
- President, Human Health Int?l
- Issuer ticker
- MRK
- Reported as of
- 30 Apr 2025
- Net transaction value
- +$184,106
- SEC form
- 4
- Accepted by SEC
- 02 May 2025, 16:14:57 UTC
- Prior SEC filing
- 02 May 2025
- Next SEC filing
- 05 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kelly E. W. Grez, attorney-in-fact for Joseph Romanelli
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joseph Romanelli filed Form 4 for Merck & Co., Inc. (MRK) on 02 May 2025.
Change
- Previous filing in this sequence was filed on 02 May 2025.
- Current net transaction value: +$184,106.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001938322
Primary reporting owner
Romanelli Joseph
- Relationship
- President, Human Health Int?l
- Address
- MERCK & CO., INC., 126 EAST LINCOLN AVENUE, RAHWAY
- Signature
- /s/ Kelly E. W. Grez, attorney-in-fact for Joseph Romanelli
- Signature date
- 02 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRK
transaction
Common Stock
Options Exercise
- Transaction value
- $174,757
- Shares
- +2,063
- Change %
- +9.9%
- Price
- $84.71
- Shares after
- 22,816
- Date
- 30 Apr 2025
- Ownership
- Direct
MRK
transaction
Common Stock
Tax liability
- Transaction value
- $86,150
- Shares
- -1,017
- Change %
- -4.5%
- Price
- $84.71
- Shares after
- 21,799
- Date
- 30 Apr 2025
- Ownership
- Direct
MRK
transaction
Common Stock
Options Exercise
- Transaction value
- $188,334
- Shares
- +2,262
- Change %
- +10%
- Price
- $83.26
- Shares after
- 24,061
- Date
- 02 May 2025
- Ownership
- Direct
MRK
transaction
Common Stock
Tax liability
- Transaction value
- $92,835
- Shares
- -1,115
- Change %
- -4.6%
- Price
- $83.26
- Shares after
- 22,946
- Date
- 02 May 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MRK
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -2,063
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 4,128
- Date
- 30 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,063
- Exercise price
- Footnotes
- F2, F3
MRK
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -2,262
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 2,262
- Date
- 02 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,262
- Exercise price
- Footnotes
- F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Holdings include shares acquired in dividend reinvestment transactions.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
Footnote F3
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
Footnote F4
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.